Page last updated: 2024-09-05

dabigatran and Erythema

dabigatran has been researched along with Erythema in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Rathgen, K; Roth, W; Shakeri-Nejad, K; Stähle, H; Stangier, J	1

Trials

1 trial(s) available for dabigatran and Erythema

Article	Year
Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment. Journal of clinical pharmacology, 2008, Volume: 48, Issue:12 Topics: Administration, Oral; Adult; Aged; Anticoagulants; Area Under Curve; Benzimidazoles; Biological Availability; Blood Proteins; Dabigatran; Erythema; Female; Glucuronides; Half-Life; Headache; Hepatic Insufficiency; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Prodrugs; Prothrombin Time; Pyridines; Severity of Illness Index; Sex Factors; Thrombin	2008

Article

Year

Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment.

Journal of clinical pharmacology, 2008, Volume: 48, Issue:12

Topics: Administration, Oral; Adult; Aged; Anticoagulants; Area Under Curve; Benzimidazoles; Biological Availability; Blood Proteins; Dabigatran; Erythema; Female; Glucuronides; Half-Life; Headache; Hepatic Insufficiency; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Prodrugs; Prothrombin Time; Pyridines; Severity of Illness Index; Sex Factors; Thrombin

2008